Navamedic’s prescription pharmaceutical for treatment of obesity draws Nordic media attention

6/1/2018 2:25:20 PM

Navamedic’s prescription pharmaceutical for treatment of obesity draws Nordic media attention

Navamedic is across the Nordics currently engaged in introducing the first oral prescription anti-obesity drug to gain EU approval in over 10 years. There has been widespread attention from Nordic media in this new treatment alternative for patients with obesity and several news outlets have published online and paper articles commenting on the new treatment.

For more info on the articles, click here

Sweden
Aftonbladet (May 2018)

Denmark
BT (April 2018)

Dagens DK (March 2018)

Finland
Helsingin Sanomat (Jan 2018)

Iltalehti (Jan 2018)

Apteekkari / Pharmacy magazine (Jan 2018)

HBL / Huvudstadsbladet (Jan 2018)